Hospira acquires insulin software

IV therapy update (IVTEAM): Hospira Inc. has acquired MD Scientific’s EndoTool business. The EndoTool software calculates the amount of insulin a patient needs to control glucose levels in critical situations. It adapts to patient responses to intravenous insulin. EndoTool also prompts caregivers when a blood-sugar reading is needed.

Click here for more information.

Other stories